| NCT06680232 | Phase 1 Study to Evaluate Safety and Antiviral Activity of PBGENE-HBV in Adult Patients With Chronic Hepatitis B | RECRUITING | PHASE1 | 2024-11-14 | 2026-12 | 2025-12 |
| NCT04649112 | Dose-escalation Study of Safety of PBCAR19B in Participants With CD19-expressing Malignancies | COMPLETED | PHASE1 | 2021-06-16 | 2023-09-30 | 2022-12-22 |
| NCT04171843 | A Dose-escalation Study to Evaluate the Safety and Clinical Activity of PBCAR269A, With or Without Nirogacestat, in Study Participants With Relapsed/Refractory Multiple Myeloma | TERMINATED | PHASE1 | 2020-04-30 | 2022-10-19 | 2022-10-19 |
| NCT04030195 | Dose-escalation Study of Safety of PBCAR20A in Subjects With r/r NHL or r/r CLL/SLL | COMPLETED | PHASE1, PHASE2 | 2020-03-24 | 2021-06-24 | 2021-06-24 |
| NCT03476681 | Study of NEO-201 in Solid Tumors Expansion Cohorts | RECRUITING | PHASE1, PHASE2 | 2019-01-18 | 2029-01-15 | 2028-01-15 |
| NCT01834235 | QUILT-3.010: A Study of Gemcitabine and Nab-paclitaxel With or Without NPC-1C to Treat Patients With Pancreatic Cancer | TERMINATED | PHASE1, PHASE2 | 2013-04 | 2019-12 | 2017-03-13 |
| NCT01040000 | QUILT-3.019: Phase 2 Study of NPC-1C Chimeric Monoclonal Antibody to Treat Pancreatic and Colorectal Cancer | COMPLETED | PHASE1, PHASE2 | 2012-01 | 2017-03 | 2017-03 |